Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
IMNM
IMNM
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
IMNM News
Immunome CSO Sells Shares Under 10b5-1 Plan
Apr 05 2026
Fool
Immunome Executive Share Sale Details
Apr 05 2026
NASDAQ.COM
Immunome Grants Stock Options to New Employees
Mar 05 2026
Yahoo Finance
Opaleye Management Sells Entire Stake in Immunome for $37.3 Million
Mar 04 2026
Fool
Opaleye Management Exits Entire Stake in Immunome
Mar 04 2026
NASDAQ.COM
Immunome Reports FY Loss and Declining Revenue Amid Public Offering
Mar 03 2026
seekingalpha
Redmile Group Increases Stake in Immunome
Feb 22 2026
Fool
Redmile Group Increases Immunome Holdings
Feb 22 2026
NASDAQ.COM
Wall Street Analysts Adjust Ratings
Feb 12 2026
Benzinga
Precision Biologics Market Awakens to $71 Billion Opportunity
Feb 05 2026
Globenewswire
Precision Biologics Market Awakens to $71 Billion Opportunity
Feb 05 2026
Newsfilter
Market Overview: Energy Stocks Show Strength
Feb 01 2026
Benzinga
IMNM Options Analysis: Put Contract Offers 27.5% YieldBoost
Jan 13 2026
NASDAQ.COM
Insider Buying Update for Friday, December 19: IMNM and S
Dec 19 2025
NASDAQ.COM
Initial Week of IMNM Options Trading for February 2026
Dec 19 2025
NASDAQ.COM
Immunome Prices 18.625M Share Offering at $21.50, Raising Approximately $400 Million
Dec 17 2025
Newsfilter
Show More News